Are Akzo Nobel latest results good or bad?

Nov 07 2025 07:22 PM IST
share
Share Via
Akzo Nobel's latest Q2 FY26 results show a net profit increase of 1,618.90% due to exceptional gains, but revenue declined by 15.01% and operating margins fell to 13.26%, indicating underlying operational challenges despite a strong balance sheet and return on equity. Investors should watch for future performance to gauge recovery potential.
Akzo Nobel's latest financial results for Q2 FY26 reveal a complex operational landscape. The company reported a net profit of ₹1,682.80 crores, which reflects a substantial year-on-year increase of 1,618.90%. However, this figure is significantly influenced by exceptional gains, masking underlying operational challenges.

In terms of revenue, net sales declined to ₹834.90 crores, marking a 15.01% decrease compared to the same quarter last year and the lowest quarterly revenue in the past two years. This decline is notable as it deviates from the company's historical growth trajectory, which averaged 12.97% annual sales growth over the previous five years. Sequentially, sales also fell by 16.10% from the preceding quarter, indicating ongoing difficulties in maintaining revenue levels.

The operating margin has also come under pressure, compressing to 13.26% from 14.90% a year ago, reflecting competitive pressures and rising costs in the decorative paints segment. This margin contraction is concerning, especially given that the company had previously enjoyed stronger operating efficiency, with historical margins averaging around 15.70%.

Despite these challenges, Akzo Nobel maintains a robust return on equity of 32.29%, indicating strong capital efficiency. The balance sheet remains strong, with zero long-term debt and a net cash position, providing the company with flexibility to navigate current operational headwinds.

The company has seen an adjustment in its evaluation, reflecting the mixed performance in its financial metrics. The significant decline in revenue and operating margins, coupled with the exceptional gains in net profit, suggests that while there are strengths in capital efficiency and balance sheet health, the operational outlook remains uncertain. Investors will need to monitor future performance closely, particularly in the upcoming quarters, to assess the potential for recovery in sales and margins.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News